|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
BendectinFrom: Dean G. Huffman (perinatl@slip.net)Sun Jan 9 16:20:45 2000
The recent posts on Bendectin prompted me to write this note. In the early 1990's, a birth defects case made it all the way to the United States Supreme Court. It involved Bendectin. The case was captioned: Daubert v. Merrell Dow Pharmaceuticals It can be found on the internet at: http://supct.law.cornell.edu/supct/html/92-102.ZS.html The issue in the case was what scientific evidence can be introduced in a federal case, and under what circumstances. I happened to be in DC that day for an ACOG meeting. I played hooky from the meeting that morning and went to the Supreme Court to see the proceedings in person. It was quite interesting. The arguments for Merrell Dow Pharmaceuticals were handled by an attorney well known within the legal community, but not very well known outside of that community. He was a former federal judge and a former United States Solicitor Generral. His name was Kenneth W. Starr, Jr. Dean Huffman
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 04:43:28 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.